GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

Rating:
Sell ARNA
up 78.11 %

Arena Pharmaceuticals, Inc. (ARNA) rated Sell by Canaccord Adams

Posted on: Monday,  Mar 16, 2009  8:25 AM ET by Canaccord Adams

Canaccord Adams rated Sell Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 03/16/2009, when the stock price was $4.72. Since
then, Arena Pharmaceuticals, Inc. has lost 43.86% as of 10/08/2015's recent price of $2.65.
If you would have followed this Canaccord Adams's recommendation on ARNA, you would have gained 78.11% of your investment in 2397 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/16/2009 8:25 AM Sell
None
4.72
as of 12/31/2009
1 Week up  47.80 %
1 Month up  47.65 %
3 Months up  57.49 %
1 YTD up  59.74 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy